🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

JAZZ JAZZ

Company Profile ↓
$261.57
+125.30% 1Y
P/E-44.79
52W High$261.62
52W Low$105.93
EPS (TTM)$-5.84

Company Overview

JAZZ (JAZZ) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 24.5% CAGR over the past five years.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $4.27B (+4.9% YoY); net profit $-356.15M.
  • Trailing 12 Months Year-on-year growth — revenue +4.9%, earnings -163.6%.
  • 5-Year Trend Long-term compounding — revenue CAGR 24.5%.

Growth & Price Performance

Compounded Sales Growth

5 Years:24.48%
1 Year:4.88%

Compounded Profit Growth

5 Years:-
1 Year:-163.58%

Stock Price Performance

1 Year:+125.30%
6 Months:+56.78%
3 Months:+23.23%
1 Month:+5.59%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 100% of range
$105.93 $261.62
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)64.70 · Neutral
Price Performance
1M+5.59%
3M+23.23%
6M+56.78%
1Y+125.30%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 24.5% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-44.79
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
24.48%
Profit 5Y
-
Revenue (YoY)
4.88%
Earnings (YoY)
-163.58%

Profitability & Returns

ROCE
-4.57%
ROE
-8.25%
ROA
-3.05%
Profit Margin
-8.35%
Op Margin
-10.08%
Gross Margin
-
EPS (Latest Qtr)
$2.78
EPS (TTM)
$-5.84

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$11.08B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
3.07%
Chg in Prom Hold
-
FII / Inst Holding
107.79%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$4.27B
EBITDA
-
Free Cash Flow
$1.30B
Operating Cash Flow
$1.36B
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue -----376.05M394.39M411.86M-444.61M500.48M469.37M476.46M508.19M534.13M537.70M581.74M534.73M562.44M600.89M665.52M607.58M751.81M838.12M813.72M932.88M940.65M892.81M957.32M972.14M901.98M1.02B1.05B-897.80M1.05B1.13B1.20B1.07B1.21B
Cost of Revenue ----------------------------------104.60M116.27M128.88M153.53M134.10M-
Gross Profit 314.89M310.48M355.13M347.31M358.96M348.61M360.98M376.77M404.85M406.93M461.38M438.62M441.00M469.82M495.75M500.92M541.18M501.55M530.20M554.85M611.15M-------------793.20M929.44M997.23M1.04B934.80M-
Operating Expenses ----------------------------------849.10M710.47M897.22M789.86M598.20M-
Operating Income -121.16M168.74M136.25M-136.14M165.04M86.45M-87.81M153.20M188.78M-133.74M204.28M133.10M--189.67M198.13M196.21M-162.12M-69.59M28.37M87.55M85.55M24.76M126.06M157.64M172.39M66.21M199.44M260.21M--55.90M218.97M100.01M254.53M336.60M248.20M
EBITDA ----------------------------------108.70M-514.11M235.86M433.05M520.50M-
Interest Expense ----------------------------------53.70M47.36M48.58M45.41M39.90M-
Pretax Income -----------------------------------109.80M-735.55M9.04M208.47M299.20M-
Tax Provision -----------------------------------17.80M-17.17M-242.42M4.96M6.10M-
Net Income 82.76M75.81M114.50M89.83M116.69M86.51M105.60M63.53M232.21M45.99M92.32M149.32M159.47M85.20M261.90M102.28M73.99M-157.83M114.80M148.23M133.41M121.83M-363.32M-52.83M1.65M34.66M-19.65M69.42M104.44M146.82M-14.62M168.57M215.06M--92.50M-718.47M251.41M203.45M293.10M192.80M
Diluted EPS 1.321.211.851.451.911.411.721.033.790.751.502.412.641.474.561.781.29-2.822.062.642.332.09-6.11-0.860.030.55-0.311.041.522.14-0.232.493.42--1.52-11.744.083.214.432.78
R&D Expense -31.25M39.09M47.80M-44.93M40.16M47.36M-62.67M56.13M51.16M-60.10M62.38M79.86M------------------------

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 128.45M173.78M272.28M585.98M872.42M1.17B1.32B1.49B1.62B1.89B2.16B2.36B3.09B3.66B3.83B4.07B4.27B
Operating Income 15.93M57.79M127.83M197.84M340.31M195.59M508.22M591.65M528.84M614.84M532.37M378.07M170.28M-65.53M578.58M716.63M-430.24M
Net Income -6.84M32.78M124.98M288.59M216.31M58.39M329.54M396.83M487.85M447.10M523.37M238.62M-329.67M-224.06M414.83M560.12M-356.15M
Diluted EPS -0.230.832.674.793.510.935.236.417.967.309.094.22-5.52-3.586.108.65-5.84
R&D Expense 36.56M25.61M14.12M20.48M41.63M85.18M135.25M162.30M198.44M226.62M299.73M------

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --135.73M253.57M1.97B2.24B3.34B3.33B4.80B5.12B5.20B5.54B6.54B12.30B10.84B11.39B12.01B11.66B
Total Equity -92.88M-72.83M30.55M192.79M1.12B1.30B1.37B1.60B1.88B2.71B2.76B3.11B3.66B3.97B3.09B3.74B4.09B4.32B
Cash & Equivalents 24.90M15.60M44.79M82.08M387.20M636.50M684.04M988.78M365.96M386.04M309.62M637.34M1.06B591.45M881.48M1.51B2.41B1.39B
Long Term Debt ---0427.07M544.40M1.33B1.15B1.99B1.54B1.56B1.57B1.85B6.02B5.69B5.11B6.08B4.33B
Current Liabilities --59.94M52.87M191.54M204.03M216.80M226.64M257.41M293.95M345.49M364.49M653.75M809.30M933.19M1.54B1.04B2.24B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -15.88M58.87M151.60M249.75M288.43M407.61M531.94M592.39M693.09M798.90M776.40M899.65M778.51M1.27B1.09B1.40B1.36B
Investing Cash Flow -6.12M-2.14M-81.23M-395.29M-16.26M-1.07B-2.25M-1.75B-268.95M-394.49M-155.30M-1.01B-5.21B-446.23M-163.06M-508.19M-1.51B
Financing Cash Flow 12.69M-27.53M-33.08M448.53M-23.86M711.03M-214.32M540.99M-409.11M-479.13M-293.75M528.07M3.97B-529.49M-305.25M20.52M-873.38M
Capital Expenditure ----------20.37M-40.13M-15.00M-27.64M-29.05M-23.96M-38.07M-58.75M
Free Cash Flow ---------778.53M736.27M884.64M750.87M1.24B1.07B1.36B1.30B
Share Buybacks --00136.48M42.22M61.55M278.30M98.80M523.67M301.45M146.54M054.00K269.76M311.43M125.02M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------------
Operating Margin % 12.4%33.3%46.9%33.8%39.0%16.7%38.4%39.8%32.7%32.5%24.6%16.0%5.5%-1.8%15.1%17.6%-10.1%
Net Margin % -5.3%18.9%45.9%49.2%24.8%5.0%24.9%26.7%30.1%23.6%24.2%10.1%-10.7%-6.1%10.8%13.8%-8.3%
ROE % 9.4%107.3%64.8%25.7%16.7%4.3%20.6%21.1%18.0%16.2%16.8%6.5%-8.3%-7.3%11.1%13.7%-8.2%
ROCE % -76.2%63.7%11.1%16.7%6.3%16.4%13.0%10.9%12.7%10.3%6.4%1.5%-0.7%5.9%6.5%-4.6%

Shareholding Pattern

Insiders
3.07%
Institutions
107.79%
Public Float
111.20%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for JAZZ

Google News Wed, 05 Aug 2026

Jazz Pharmaceuticals' Re-Rating Story Has Legs (NASDAQ:JAZZ) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOMmpwZVgxVFRtR1MwdlA3Zmx4and1X0xDTnkzYlB6TmgwQmVjbXdxSHlkUElKTWxmODM3LVJINGFwUlB1b3VYV3l2c3RMdkxiUEJMSmtsTGtjMUtOaGxZMU5NZHFOTVplRHNrRU54Y2s1S3BuSzRSQ2N0UEdsVkNRX19oZHhZMVlSTHV2cj…

Google News Mon, 03 Aug 2026

Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results - PR Newswire

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOS2ZnUHhXR19TOW4tZmV2VjZUMEpiQVMwTDhVSDVlLTlGV0pTZVRSRGItNkNFNGd1VXQwbTM5QzBaMU1YM3I0YVVIOE92QjExRDN3TkZQRHdZblVEQnpibW5RV0VnN1A3QklDLTdaRTVvYnJaUzBiSVBqTFRUZk1VRkdMQXM3YzdhU2E1Tl…

Google News Wed, 05 Aug 2026

Jazz Pharmaceuticals stock hits all-time high at 261.46 USD - Investing.com

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQZjVkMFM3YUl4dHR0anpqcGRtZmtRMGFaTElkSlpONklPbWlWSW03NjduSDBDdXU1ODFYdVZKNG5rRF9mbFMwQ3lQeWJrSzVPdUM1RjAzMk9YMTUxLXJyZDZaUnhpcFlTSUF4a2NLb0FpREF3TWFWX181ck4yaENINnNYa1gyVDZ3d29RYX…

Google News Wed, 05 Aug 2026

Jazz Pharmaceuticals (JAZZ) Stock Climbs As Raised Guidance Backs Oncology Push - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxNR1RpZlAwYzViakw0WnMwb0IxbzRsd0VJVkpuM2tSU2NnMWlFVV9keTBHNDY5T1RmR1hKcklrMmltQl93c0J3SlFjY0hfa0p1LWU4TjFZWmxzNTg1cHpEUTdQME8xR2c0TDh1d25yY1BBaWcxaUhxLW9jc0U3RGo0Z3NUZDdQYmlOc05tYn…

Google News Sat, 18 Jul 2026

Jazz Pharmaceuticals (JAZZ) Stock Still Looks Like A Bargain After A 119% Run - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQX0Q0bXgyRnRJRTJwa1lURWZ3SEJoZ0VTeGZ0eEwxOFQxUXhsMXFQVnFsVjhBU3dRMk5FZDVYdEpYOE1qQ3BKQjJ0bEtnbzMyMnNDOUJLZER4cmQ5YVF1Z3ozeHpIQmozTlVwU3MtVkpCQVhuMURiSWNfNFgzdjhVMEFLbDcyaGdGcGx3WV…

Google News Mon, 03 Aug 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales - StockStory

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOVDhIN0ZjZTJRT3F0dnlQZlE1WjRlcHpfUHJKOVB0ZkR5U0FiZFZ1ZzNkUjlSajI3eXBSdDJjQkdma0JPNG1aUndOVFR6Vm91TDRNT1N0VjhHTTNzMW5HWGhOc0hyWEdtWEI1QUZCc3pDaGRXZ1IwVTVPcEszZzJCbEdmT2sySWFZVTRXUH…

JAZZ — Frequently Asked Questions

What is the current share price of JAZZ?

As of 2026-08-05 17:25 PDT, JAZZ trades at $261.57 on NASDAQ/NYSE. Its 52-week range is $105.93 to $261.62.

What is the P/E ratio of JAZZ?

JAZZ trades at a trailing price-to-earnings (P/E) ratio of -44.79.

What is the return on equity (ROE) of JAZZ?

JAZZ has a return on equity (ROE) of -8.25%. Its return on capital employed (ROCE) is -4.57%.

Is JAZZ a good stock to buy?

This page provides a data-driven analysis of JAZZ, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space